Trial intelligence / Profile preview

Osteopathic Vagus Nerve Stimulation in Cancer Patients

NCT04718610Terminated

Sponsor
Centre Hospitalier d'Avignon
Start
Jan 2021
Primary completion
Sep 2021
Countries
1
01

Overview

Randomised, open-label trial in lung cancer, colorectal cancer (CRC), multiple myeloma (MM) and 1 more (2 arms), sponsored by Centre Hospitalier d'Avignon. Primary endpoint: Standard Deviation of all NN intervals at 84 days. Started Jan 2021; status: terminated.

02

Conditions

lung cancercolorectal cancer (CRC)multiple myeloma (MM)non-Hodgkin lymphoma (NHL)

Beyond the preview

Go deeper on NCT04718610.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04718610.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call